{"id":"agonist-gnrh-estradiol-valerate-progesterone","safety":{"commonSideEffects":[{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Hot flashes"},{"rate":null,"effect":"Injection site reactions"},{"rate":null,"effect":"Mood changes"},{"rate":null,"effect":"Breast tenderness"},{"rate":null,"effect":"Ovarian hyperstimulation syndrome (OHSS)"}]},"_chembl":{"chemblId":"CHEMBL1511","moleculeType":"Small molecule","molecularWeight":"356.51"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"The GnRH agonist downregulates the pituitary to prevent premature luteinizing hormone (LH) surge during controlled ovarian hyperstimulation. Estradiol valerate and progesterone are then administered exogenously to mimic natural hormone levels and support endometrial development and embryo implantation during in vitro fertilization (IVF) protocols.","oneSentence":"This combination suppresses endogenous gonadotropins via GnRH agonist while providing exogenous estradiol and progesterone to support the luteal phase during assisted reproductive cycles.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T00:26:52.958Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Assisted reproductive technology (ART) / in vitro fertilization (IVF) support"},{"name":"Controlled ovarian hyperstimulation in infertility treatment"}]},"trialDetails":[{"nctId":"NCT06239376","phase":"NA","title":"Artificial Cycle With or Without GnRH Agonist Pre-treatment for Frozen Embryo Transfer in Adenomyosis Patients","status":"RECRUITING","sponsor":"Mỹ Đức Hospital","startDate":"2024-02-19","conditions":"Adenomyosis, IVF, Frozen Embryo Transfer","enrollment":222},{"nctId":"NCT00001481","phase":"PHASE2","title":"The Role of Hormones in Postpartum Mood Disorders","status":"COMPLETED","sponsor":"National Institute of Mental Health (NIMH)","startDate":"1996-04-26","conditions":"Postpartum Depression","enrollment":74},{"nctId":"NCT07171970","phase":"NA","title":"IVM - Fresh ET (THE SAIGON PROTOCOL) Versus IVF - FET in PCOS Women","status":"RECRUITING","sponsor":"Mỹ Đức Hospital","startDate":"2025-09-22","conditions":"Polycystic Ovary Syndrome (PCOS), In Vitro Maturation of Oocytes, Fresh Embryo Transfer","enrollment":600},{"nctId":"NCT06455969","phase":"PHASE4","title":"Adaptions and Resiliency to Multi-Stressor OpeRations","status":"RECRUITING","sponsor":"Bradley Nindl","startDate":"2024-07-15","conditions":"Musculoskeletal Injury, Hypogonadism","enrollment":120},{"nctId":"NCT04721522","phase":"","title":"The Impact of Endometrial Compaction on Assisted Reproductive Technology Outcome","status":"RECRUITING","sponsor":"Zagazig University","startDate":"2021-01-29","conditions":"Embryo Implantation, ART","enrollment":356},{"nctId":"NCT04989348","phase":"NA","title":"Euploid Rate of Blastocyst Derived From PPOS VS Antagonist Protocol","status":"COMPLETED","sponsor":"Shanghai First Maternity and Infant Hospital","startDate":"2021-08-04","conditions":"IVF","enrollment":240},{"nctId":"NCT00001259","phase":"PHASE1","title":"A Treatment Study for Premenstrual Syndrome (PMS)","status":"COMPLETED","sponsor":"National Institute of Mental Health (NIMH)","startDate":"1992-08-11","conditions":"Premenstrual Syndrome, Menstruation Disturbances","enrollment":60},{"nctId":"NCT00001322","phase":"PHASE1, PHASE2","title":"The Effects of Reproductive Hormones on Mood and Behavior","status":"COMPLETED","sponsor":"National Institute of Mental Health (NIMH)","startDate":"1994-06-09","conditions":"Healthy Volunteers","enrollment":100},{"nctId":"NCT05189873","phase":"PHASE3","title":"GnRH Agonist Plus Hormone Replacement Therapy vs Hormone Replacement Therapy on IVF Outcomes","status":"COMPLETED","sponsor":"Tehran University of Medical Sciences","startDate":"2021-06-10","conditions":"Polycystic Ovary Syndrome, Infertility, Female","enrollment":128},{"nctId":"NCT02122198","phase":"NA","title":"Vascular Mechanisms for the Effects of Loss of Ovarian Hormone Function on Cognition in Women","status":"COMPLETED","sponsor":"University of Colorado, Denver","startDate":"2014-09-08","conditions":"Cognitive Impairment, Executive Dysfunction, Endothelial Dysfunction","enrollment":17},{"nctId":"NCT05143723","phase":"PHASE2","title":"Luteal Phase Support With Daily Administration of Gonadotropin-releasing Hormone Agonist Compared to Progesterone/Estradiol in IVF/ICSI Cycles With Ovulation Triggering With GnRH-a","status":"UNKNOWN","sponsor":"Kuban State Medical University","startDate":"2020-01-20","conditions":"Infertility","enrollment":102},{"nctId":"NCT04797338","phase":"PHASE4","title":"Gonadotropin Releasing Hormone Agonist (GnRHa) Versus Estrogen and Progesterone for Luteal Support in High Responders","status":"UNKNOWN","sponsor":"Assaf-Harofeh Medical Center","startDate":"2017-12-29","conditions":"Pregnancy Early, Miscarriage, Ovarian Hyperstimulation Syndrome","enrollment":100},{"nctId":"NCT04454749","phase":"","title":"Endometrial Compaction and Its Influence on Pregnancy Rate in Frozen Embryo Cycle Regimes","status":"TERMINATED","sponsor":"ART Fertility Clinics LLC","startDate":"2020-11-09","conditions":"Endometrial Disorder, Infertility, Female, IVF","enrollment":3},{"nctId":"NCT01943812","phase":"PHASE4","title":"Substituted Frozen Embryo Transfer Cycles With GnRH-agonist Supplementation","status":"COMPLETED","sponsor":"Peter Humaidan","startDate":"2013-12","conditions":"Pregnancy Loss, Frozen Embryo Transfer","enrollment":287},{"nctId":"NCT00005011","phase":"","title":"Combined Hormone Replacement in Menstrually-Related Mood Disorders","status":"COMPLETED","sponsor":"National Institute of Mental Health (NIMH)","startDate":"2000-03-28","conditions":"Premenstrual Syndrome, Depression","enrollment":22},{"nctId":"NCT03837223","phase":"","title":"RESCUE PROTOCOL AND FRESH EMBRYO TRANSFER","status":"COMPLETED","sponsor":"Istituto Clinico Humanitas","startDate":"2013-03-01","conditions":"GnRH Trigger and Rescue Protocol","enrollment":271},{"nctId":"NCT02757287","phase":"PHASE4","title":"Desogestrel (DSG) and Corifollitropin(FSH-CTP) Alfa for Ovarian Stimulation in Donors","status":"WITHDRAWN","sponsor":"Fundacion Dexeus","startDate":"2016-05","conditions":"Infertility","enrollment":""},{"nctId":"NCT02736032","phase":"PHASE3","title":"Cryopreserved-thawed Embryo Transfer With or Without Gonadotropin Releasing Hormone Agonist","status":"COMPLETED","sponsor":"Cairo University","startDate":"2016-03","conditions":"Infertility","enrollment":310},{"nctId":"NCT03353883","phase":"PHASE2, PHASE3","title":"Early Preparation With Gonadotropin- Releasing Hormon (GnRh) Agonists Injection With Frozen-Thawed Embryo Transfer?","status":"UNKNOWN","sponsor":"Benha University","startDate":"2017-06-01","conditions":"Infertility, Female","enrollment":200},{"nctId":"NCT03237117","phase":"EARLY_PHASE1","title":"Effect of Growth Hormone on Uterine Receptivity in Women With RIF in an Oocyte Donation Program","status":"UNKNOWN","sponsor":"Competence Centre on Health Technologies","startDate":"2010-01-01","conditions":"Female Infertility","enrollment":105},{"nctId":"NCT03005275","phase":"NA","title":"A Comparison of Cost - Effectiveness of Stimulated ICSI and IVM Strategy in PCOS Women","status":"WITHDRAWN","sponsor":"Vietnam National University","startDate":"2017-01","conditions":"Infertility","enrollment":""},{"nctId":"NCT02620124","phase":"PHASE4","title":"GnRH Agonist as Luteal Support in FET Cycles","status":"COMPLETED","sponsor":"Turku University Hospital","startDate":"2013-05","conditions":"Infertility","enrollment":100},{"nctId":"NCT01500863","phase":"PHASE4","title":"Endometrial Receptivity After GnRH Agonist Triggering","status":"COMPLETED","sponsor":"IVI Madrid","startDate":"2011-11","conditions":"Ovarian Hyperstimulation Syndrome","enrollment":35},{"nctId":"NCT02449642","phase":"","title":"LH Hormone Pulsation in the Luteal Phase in GnRH Antagonist IVF Cycles Triggered by GnRH Agonist for Final Oocyte Maturation","status":"COMPLETED","sponsor":"Rambam Health Care Campus","startDate":"2015-07","conditions":"Infertility","enrollment":10},{"nctId":"NCT02251925","phase":"PHASE3","title":"Frozen Embryo Transfer in Natural and Hormonal Replacement Cycles","status":"UNKNOWN","sponsor":"Royan Institute","startDate":"2012-09","conditions":"Infertility","enrollment":460},{"nctId":"NCT02114645","phase":"NA","title":"The Effect of GnRH Agonist Administered in the Luteal Phase on ART Cycle Outcomes","status":"UNKNOWN","sponsor":"Zekai Tahir Burak Women's Health Research and Education Hospital","startDate":"2014-04","conditions":"Infertility","enrollment":100},{"nctId":"NCT01888744","phase":"PHASE4","title":"Preimplantation Genetic Diagnosis (PGD) With Gonadotropin-releasing Hormone (GnRH) Agonist Versus Antagonist","status":"COMPLETED","sponsor":"Universitair Ziekenhuis Brussel","startDate":"2010-09","conditions":"Reproductive Endocrinology, Fertility, Optimal Stimulation Protocol","enrollment":120},{"nctId":"NCT01353846","phase":"PHASE4","title":"Comparison Between Natural and Artificial Cycle in Recipient Oocyte Patients","status":"UNKNOWN","sponsor":"Instituto Valenciano de Infertilidad, IVI VALENCIA","startDate":"2011-05","conditions":"Infertility","enrollment":70},{"nctId":"NCT01424618","phase":"NA","title":"A Novel Approach to Endometrial Preparation in Recipients of Donor Eggs","status":"UNKNOWN","sponsor":"Kelly, Maureen, M.D.","startDate":"2006-01","conditions":"Implantation, Embryo","enrollment":20}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":676,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Decapeptyl (IPSEN)3.75 mg.","Progynova 1 mg (Bayer Schering Farma)","Natural micronized progesterone 400 mg/12 hours"],"phase":"marketed","status":"active","brandName":"Agonist GnRH; estradiol Valerate; progesterone","genericName":"Agonist GnRH; estradiol Valerate; progesterone","companyName":"Instituto Valenciano de Infertilidad, IVI VALENCIA","companyId":"instituto-valenciano-de-infertilidad-ivi-valencia","modality":"Small molecule","firstApprovalDate":"","aiSummary":"This combination suppresses endogenous gonadotropins via GnRH agonist while providing exogenous estradiol and progesterone to support the luteal phase during assisted reproductive cycles. Used for Assisted reproductive technology (ART) / in vitro fertilization (IVF) support, Controlled ovarian hyperstimulation in infertility treatment.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}